On Friday, Tenaya Therapeutics Inc (NASDAQ: TNYA) was 8.87% up from the session before settling in for the closing price of $1.24. A 52-week range for TNYA has been $0.36 – $4.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -15.48%. When this article was written, the company’s average yearly earnings per share was at 47.83%. With a float of $137.66 million, this company’s outstanding shares have now reached $162.98 million.
Tenaya Therapeutics Inc (TNYA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tenaya Therapeutics Inc stocks. The insider ownership of Tenaya Therapeutics Inc is 15.53%, while institutional ownership is 18.01%. The most recent insider transaction that took place on Aug 18 ’25, was worth 3,711. In this transaction SVP, Finance of this company sold 2,962 shares at a rate of $1.25, taking the stock ownership to the 95,338 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Chief Medical Officer sold 5,053 for $1.25, making the entire transaction worth $6,331. This insider now owns 172,803 shares in total.
Tenaya Therapeutics Inc (TNYA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.3 earnings per share (EPS) during the time that was better than consensus figure (set at -0.37) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
You can see what Tenaya Therapeutics Inc (TNYA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Looking closely at Tenaya Therapeutics Inc (NASDAQ: TNYA), its last 5-days average volume was 3.17 million, which is a jump from its year-to-date volume of 2.97 million. As of the previous 9 days, the stock’s Stochastic %D was 83.08%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 90.83%, which indicates a significant increase from 81.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1360 in the past 14 days, which was higher than the 0.0672 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8567, while its 200-day Moving Average is $1.0478. However, in the short run, Tenaya Therapeutics Inc’s stock first resistance to watch stands at $1.3933. Second resistance stands at $1.4367. The third major resistance level sits at $1.5033. If the price goes on to break the first support level at $1.2833, it is likely to go to the next support level at $1.2167. Now, if the price goes above the second support level, the third support stands at $1.1733.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are 162,976K outstanding shares of the company, which has a market capitalization of 220.02 million. As of now, sales total 0 K while income totals -111,130 K. Its latest quarter income was 0 K while its last quarter net income were -23,280 K.
